Ampa is a neurotechnology company using breakthroughs in neuroscience to create practical tools that help people recover their mental health. Its FDA-cleared Ampa One system and emerging Ampa One Day protocol advance the mission of one billion remissions from mental and neurological disorders.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/22/25 | $8,500,000 |
Nexus NeuroTech Ventures | undisclosed |
